摘要
1文献来源Janjigian YY,Shitara K,Moehler M,et al.First-line nivolumab plus chemotherapy versus chemothera-py alone for advanced gastric,gastro-oesophageal junction,and oesophageal adenocarcinoma(Check-Mate 649):A randomised,open-label,phase 3 trial[J].Lancet,2021,398(10294):27-40.
作者
杨慧
张俊
YANG Hui;ZHANG Jun(Department of Oncology,Ruijin Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200025,China)
出处
《循证医学》
2021年第5期262-265,共4页
The Journal of Evidence-Based Medicine
